Logo

American Heart Association

  109
  0


Final ID:

αIIbβ3 to αVβ3

  • Coller, Barry  ( The Rockerfeller University , New York , New York , United States )
  • Author Disclosures:
    Barry Coller: DO have relevant financial relationships ; Royalties/Patent Beneficiary:CeleCor Therapeutics:Active (exists now) ; Royalties/Patent Beneficiary:Centocor:Past (completed) ; Royalties/Patent Beneficiary:Accumetrics/Werfen:Past (completed) ; Advisor:Platelet Biogenesis:Past (completed) ; Advisor:Chugai Pharmaceuticals:Active (exists now) ; Advisor:Scholar Rock:Past (completed) ; Individual Stocks/Stock Options:CeleCor Therapeutics:Active (exists now) ; Advisor:CeleCor Therapeutics:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:
More abstracts from these authors:
Introduction to the Sol Sherry Lecture

Coller Barry

Prehospital treatment with Disaggprotm (Zalunfiban) in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention: Final results of the CELEBRATE trial

Van 't Hof Arnoud, Kala Petr, Levy Mike, Arkenbout Karin, Pisters Ron, Hermanides Rik, Van Houwelingen Gert, Vainer Jindra, Rasoul Saman, Arslan Fatih, Remkes Wouter, Rikken Sem, Van Vliet Risco, Van Den Branden Ben, Van De Wetering Henri, Lapostolle Frederic, Polad Jawed, Verburg Ashley, Van De Hoef Tim, Postma Sonja, Welsh Robert, Arias-mendoza Alexandra, Coller Barry, Tijssen Jan, Wittes Janet, Mosterd Arend, Berg Jm Ten, Gibson Charles, Montalescot Gilles, Van Beurden Antony, Granger Christopher, Januzzi James, Vinereanu Dragos, Merkely Béla

You have to be authorized to contact abstract author. Please, Login
Not Available